Anuradha Chakravarthy
Faculty Member
Last active: 3/30/2020


None provided


The following timeline graph is generated from all co-authored publications.

Featured publications are shown below:

  1. A randomized placebo-controlled pilot study of the impact of healing touch on fatigue in breast cancer patients undergoing radiation therapy. FitzHenry F, Wells N, Slater V, Dietrich MS, Wisawatapnimit P, Chakravarthy AB (2014) Integr Cancer Ther 13(2): 105-13
    › Primary publication · 24105358 (PubMed)
  2. Early assessment of breast cancer response to neoadjuvant chemotherapy by semi-quantitative analysis of high-temporal resolution DCE-MRI: preliminary results. Abramson RG, Li X, Hoyt TL, Su PF, Arlinghaus LR, Wilson KJ, Abramson VG, Chakravarthy AB, Yankeelov TE (2013) Magn Reson Imaging 31(9): 1457-64
    › Primary publication · 23954320 (PubMed) · PMC3807825 (PubMed Central)
  3. Four jointed box 1 promotes angiogenesis and is associated with poor patient survival in colorectal carcinoma. Al-Greene NT, Means AL, Lu P, Jiang A, Schmidt CR, Chakravarthy AB, Merchant NB, Washington MK, Zhang B, Shyr Y, Deane NG, Beauchamp RD (2013) PLoS One 8(7): e69660
    › Primary publication · 23922772 (PubMed) · PMC3726759 (PubMed Central)
  4. A mechanically coupled reaction-diffusion model for predicting the response of breast tumors to neoadjuvant chemotherapy. Weis JA, Miga MI, Arlinghaus LR, Li X, Chakravarthy AB, Abramson V, Farley J, Yankeelov TE (2013) Phys Med Biol 58(17): 5851-66
    › Primary publication · 23920113 (PubMed) · PMC3791925 (PubMed Central)
  5. Pattern of breast cancer susceptibility gene 1 expression is a potential prognostic biomarker in resectable pancreatic ductal adenocarcinoma. Wang T, Wentz SC, Ausborn NL, Washington MK, Merchant N, Zhao Z, Shyr Y, Chakravarthy AB, Xia F (2013) Pancreas 42(6): 977-82
    › Primary publication · 23851432 (PubMed) · PMC4026161 (PubMed Central)
  6. Parameterizing the Logistic Model of Tumor Growth by DW-MRI and DCE-MRI Data to Predict Treatment Response and Changes in Breast Cancer Cellularity during Neoadjuvant Chemotherapy. Atuegwu NC, Arlinghaus LR, Li X, Chakravarthy AB, Abramson VG, Sanders ME, Yankeelov TE (2013) Transl Oncol 6(3): 256-64
    › Primary publication · 23730404 (PubMed) · PMC3660793 (PubMed Central)
  7. DCE-MRI analysis methods for predicting the response of breast cancer to neoadjuvant chemotherapy: pilot study findings. Li X, Arlinghaus LR, Ayers GD, Chakravarthy AB, Abramson RG, Abramson VG, Atuegwu N, Farley J, Mayer IA, Kelley MC, Meszoely IM, Means-Powell J, Grau AM, Sanders M, Bhave SR, Yankeelov TE (2014) Magn Reson Med 71(4): 1592-602
    › Primary publication · 23661583 (PubMed) · PMC3742614 (PubMed Central)
  8. Machine learning for predicting the response of breast cancer to neoadjuvant chemotherapy. Mani S, Chen Y, Li X, Arlinghaus L, Chakravarthy AB, Abramson V, Bhave SR, Levy MA, Xu H, Yankeelov TE (2013) J Am Med Inform Assoc 20(4): 688-95
    › Primary publication · 23616206 (PubMed) · PMC3721158 (PubMed Central)
  9. Time course of arthralgia among women initiating aromatase inhibitor therapy and a postmenopausal comparison group in a prospective cohort. Castel LD, Hartmann KE, Mayer IA, Saville BR, Alvarez J, Boomershine CS, Abramson VG, Chakravarthy AB, Friedman DL, Cella DF (2013) Cancer 119(13): 2375-82
    › Primary publication · 23575918 (PubMed) · PMC3687009 (PubMed Central)
  10. 53BP1 expression is a modifier of the prognostic value of lymph node ratio and CA 19-9 in pancreatic adenocarcinoma. Ausborn NL, Wang T, Wentz SC, Washington MK, Merchant NB, Zhao Z, Shyr Y, Chakravarthy AB, Xia F (2013) BMC Cancer : 155
    › Primary publication · 23530749 (PubMed) · PMC3636043 (PubMed Central)
  11. Lymph node ratio and preoperative CA 19-9 levels predict overall survival and recurrence-free survival in patients with resected pancreatic adenocarcinoma. Wentz SC, Zhao ZG, Shyr Y, Shi CJ, Merchant NB, Washington K, Xia F, Chakravarthy AB (2012) World J Gastrointest Oncol 4(10): 207-15
    › Primary publication · 23444312 (PubMed) · PMC3581835 (PubMed Central)
  12. A phase I study of cetuximab in combination with gemcitabine and radiation for locally advanced pancreatic cancer. Chakravarthy AB, Tsai CJ, O'Brien N, Lockhart AC, Chan E, Parikh A, Berlin JD, Merchant N (2012) Gastrointest Cancer Res 5(4): 112-8
    › Primary publication · 23077684 (PubMed) · PMC3433259 (PubMed Central)
  13. Survival Benefit of Adjuvant Radiation Therapy for Gastric Cancer following Gastrectomy and Extended Lymphadenectomy. Snyder RA, Castaldo ET, Bailey CE, Phillips SE, Chakravarthy AB, Merchant NB (2012) Int J Surg Oncol : 307670
    › Primary publication · 22778937 (PubMed) · PMC3388431 (PubMed Central)
  14. Early prediction of the response of breast tumors to neoadjuvant chemotherapy using quantitative MRI and machine learning. Mani S, Chen Y, Arlinghaus LR, Li X, Chakravarthy AB, Bhave SR, Welch EB, Levy MA, Yankeelov TE (2011) AMIA Annu Symp Proc : 868-77
    › Primary publication · 22195145 (PubMed) · PMC3243164 (PubMed Central)